Generics 11

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Anidulafungin manufacturers

11 products found

Filters

11 products found

anidulafungin

Powder for solution for infusion 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Storage +2 - +8 C
Manufacturer #1586
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe, the Middle East, CIS, LATAM, and Asia for 10+ years. The company's production lines are GMP-compliant. Main dosage forms include solid, liquid, and injection. The company prepares dossier in EU CTD format.

Manufacturer usually replies in 6 days

anidulafungin

Vials, lyophilized injection 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Unavailable markets
Vietnam
Manufacturer #2272
The company integrates and applies enormous experience and technology in the field of hospital products. Their goal is to become a global leader in intensive care units and maintain that position. The company's headquarters were established in Europe in 1980ies, and serum production was continuing in a plant in Europe till the end of the 2000s. With a nationwide market share of 50%, it has become one of the leading serum producers. They've already started making the first ready-to-use injections.

Manufacturer usually replies in 7 days

anidulafungin

Injection, lyophilized 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS, Turkey
Available for
Licensing with supply, Distribution only
Comments
Reference Product : Eraxis/Ecalta
Manufacturer #2748
It is a privately held pharmaceutical company based in southeast Europe that was established in the 1990s to import and introduce pharmaceutical items into medicine. The company began by importing hemophilia and intensive care supplies, as well as immunoglobulin-containing items. To suit market demands, the company has added additional dermatological, cardiological, urological, and surgical goods to its portfolio since then. They now offer a diverse product line that includes not only prescription but also OTC, medical gadgets, and dermo-cosmetics.

Manufacturer usually replies in 7 days

anidulafungin

Vials, injection 50 mg , 100 mg/30 ml

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Germany , South Africa , Thailand , United Kingdom , Vietnam , Chile
Manufacturer #11531

Manufacturer usually replies in 6 days

anidulafungin

Vials, injection 100 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #9406

Manufacturer usually replies in 7 days

anidulafungin

Injection 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17417

Manufacturer usually replies in 6 days

anidulafungin

Vials, lyophilized injection 100 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
Turkey
Manufacturer #10966
It is a well-known international pharmaceutical company with operations in more than 15 countries. Orphan illness, plasma products, hospital injectables, vaccines, and particular OTC products are among the company's specialties. The company, which believes that every patient deserves current treatment options and a great quality of life, formed its R&D department in the 2010s and has been working hard since to develop and produce specialized products.

Manufacturer usually replies in 8 days

anidulafungin

Vials, injection 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, WHO, PICS
Manufacturer #12792

Manufacturer usually replies in 6 days

anidulafungin

Injection 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19828

Manufacturer usually replies in 14 days

anidulafungin

Vials, lyophilized injection 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #1430

Manufacturer usually replies in nan days

anidulafungin

Injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #31070

Manufacturer usually replies in nan days

Anidulafungin

Anidulafungin is an antifungal medication used to treat fungal infections. It is mainly used to cure infections in the blood, abdomen, or stomach, and esophagus. It is effective in treating candidemia and other forms of candida infections, which occur in intra-abdominal abscess, and peritonitis, aspergillus infections, and esophageal candidiasis, and recommended for the treatment of or pharyngeal candidiasis. It is a semi-synthetic lipopeptide synthesized while fermenting Aspergillus nidulans. Anidulafungin is sold under the trade names Eraxis, Ecalta, and Andulfa amongst others. Due to the common occurrence of these infections around the world, this medicine is manufactured and supplied by companies around the world. Vicuron Pharmaceuticals originally manufactured and submitted for FDA approval. Pfizer acquired the drug upon its acquisition of Vicuron in the fall of 2005 and got FDA approval in, 2006.

Forms and Dosage:

Anidulafungin is a white to off-white powder. It is practically insoluble in water and slightly soluble in ethanol. It is available as injection, lyophilized product for intravenous (IV) infusion. In the treatment of Candidemia, Candidal Peritonitis, Intra-Abdominal Abscess, the recommended initial dose is 200 mg through an IV infusion, followed by 100 mg per day from day 2. This medicine should be administered 14 days after the last positive culture. In the treatment of Esophageal Candidiasis, the initial adult dose is 100 mg through an IV infusion, followed by 50 mg per day, from day 2. This treatment has to be continued for at least 2 weeks and at least for a week post-resolution of symptoms. Off-label, Anidulafungin has also been used to treat Candida Auris, and based on the latest tests it has been recommended by the CDC as initial therapy for the treatment of C Auris infections. In the treatment of these infections, the initial adult dose is 200 mg and 100 mg from day2.

The cost of Anidulafungin

In the USA, the consumers have to pay around $103 for a supply of 1 powder for injection, of 50 mg quantity. In India, a100mg vials are sold at USD130 for 1 injection.

How does Anidulafungin work?

Anidulafungin is a cyclic lipopeptide echinocandin derivative. This enzyme is important for fungal cell wall synthesis, which results in the final cell lysis and death. The active agent works against Candida species and Aspergillus. It is different in that it inhibits glucan synthase, but not mammalian cells. Overall resulting in inhibition of the formation of 1,3-β- D-glucan, ultimately leading to osmotic instability and cell death.

Finding Anidulafungin Manufacturers and Suppliers

The best way to find and gain access to Anidulafungin manufacturers and Anidulafungin suppliers are to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Anidulafungin can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Anidulafungin to work with. You can fine-tune your search results using various filters too, letting you search for Anidulafungin from specific countries, for example.